A Comparison of Pharmacotherapy and Psychotherapy in the Treatment of Erectile Dysfunction
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 116
- Locations
- 1
- Primary Endpoint
- International Index of Erectile Functioning-5
Study Overview
Brief Summary
The study involved the administration of pharmacotherapy and cognitive behavior psychotherapy to individuals suffering from erectile dysfunction. The study was randomized controlled trial with four arms involving a control group.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Sequential
- Primary Purpose
- Other
- Masking
- Single (Participant)
Eligibility Criteria
- Ages
- 18 Years to 40 Years (Adult)
- Sex
- Male
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Men diagnosed with erectile dysfunction
- •Must be in the age range of 18 to 40 years
- •Must be in a stable heterosexual relationship
- •Must not be suffering from any medical or psychiatric illness
Exclusion Criteria
- •Men not meeting criteria of diagnosis of erectile dysfunction
- •Men not in a heterosexual relationship
- •Men above the age of 40 years
- •Men diagnosed with any medical or psychiatric illness
Arms & Interventions
Group A
This arm received pharmacotherapy for erectile dysfunction.
Intervention: Sildenafil Citrate 50Mg Tab (Drug)
Group B
This arm received cognitive behavior psychotherapy for erectile dysfunction.
Intervention: Cognitive Behavioral Psychotherapy (Behavioral)
Group C
This arm received combined treatment approach.
Intervention: Combined or Integrated Therapy (Combination Product)
Group D
This arm acted as a control group and received placebo or no intervention.
Intervention: Placebo (Other)
Outcomes
Primary Outcomes
International Index of Erectile Functioning-5
Time Frame: 3 months maximum
Secondary Outcomes
No secondary outcomes reported
Investigators
Ahmad Bilal
Principal Investigator, PhD Research Candidate
International Islamic University, Islamabad